Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Severe Pandemic H1N1 Infection in ICU: Comparative Resource Utilization

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Dr. Anand Kumar, University of Manitoba
ClinicalTrials.gov Identifier:
NCT01485237
First received: December 1, 2011
Last updated: December 1, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)